By Olayiwola Mercy
The UK Health Security Agency (UKHSA) announced on Thursday that a new mpox strain has been detected in England, marking the first time the recombinant virus has been identified outside the African continent. Health officials said the case involves a patient who recently returned from a trip to Southeast Asia, where the novel strain was first flagged by local surveillance systems. Genome sequencing confirmed that the virus combines elements of clade Ib and clade IIb, a mix that hadn’t been seen before in the UK.
UKHSA’s rapid response team has already traced the individual’s close contacts and initiated monitoring to prevent any onward transmission. While the agency stressed that the risk to the general public remains low, they have urged anyone who had direct contact with the patient in the past two weeks to be vigilant for symptoms such as fever, swallowing pain, and the characteristic rash that starts on the face before spreading. Free testing and, if needed, vaccination are being offered to those at highest risk.
The emergence of this recombinant strain underscores the importance of global disease surveillance. The UK’s partnership with the World Health Organization and regional health bodies helped flag the case quickly, allowing for a coordinated response. Experts note that mpox, like many viruses, is prone to genetic changes, but the speed at which this particular recombination was identified is a testament to improved sequencing capabilities.
Public health messaging is focusing on dispelling misinformation. The UKHSA clarified that the new strain does not appear to be more transmissible or deadly than previously known variants, and existing vaccines remain effective. They also reminded the public that mpox spreads primarily through close, skin‑to‑skin contact, and that routine hygiene practices—hand‑washing, avoiding contact with infected lesions, and using protection during intimate encounters—are still the best defenses.
In response to the finding, the UK government is reviewing its mpox vaccination strategy, particularly for high‑risk groups such as healthcare workers, men who have sex with men, and individuals with multiple sexual partners. The Department of Health and Social Care said it will consider expanding the eligibility criteria if the situation evolves, but for now the focus is on targeted protection and swift containment.
The UKHSA’s announcement comes just weeks after the World Health Organization declared mpox a public health emergency of international concern. While the new strain adds a layer of complexity, health officials remain optimistic that, with robust surveillance, rapid testing, and clear communication, any potential outbreak can be kept under control. As the investigation continues, the agency is urging anyone with concerns to contact their local health provider or the NHS hotline for guidance.
